MAVERICK CAPITAL LTD

Holdings History for ROCKET PHARMACEUTICALS, INC. - Common stock, $0.01 par value per share (RCKT)

Symbol: RCKT on Nasdaq
Investment type: Equity / Common stock, $0.01 par value per share
Latest Disclosed Shares Owned: 2,513,110 shares
Security Ownership %: 2.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Maverick Capital, Ltd. ownership in ROCKET PHARMACEUTICALS, INC. Common stock, $0.01 par value per share (RCKT)

13 Feb 2026 - Maverick Capital, Ltd. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,513,110 shares of ROCKET PHARMACEUTICALS, INC. Common stock, $0.01 par value per share (RCKT). This represents 2.3% ownership of the company. In their previous filing dated 14 Aug 2025, MAVERICK CAPITAL LTD had reported owning 8,363,813 shares, indicating a decrease of +70%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Maverick Capital, Ltd.	2.3%	-69%	$9,549,818	2,513,110	-5,850,703	-70%	$3.80	13G/A	31 Dec 2025	13 Feb 2026, 16:10
Maverick Capital, Ltd.	7.8%	+52%	$26,429,649	8,363,813	+2,816,638	+51%	$3.16	13G/A	30 Jun 2025	14 Aug 2025, 08:00
Maverick Capital, Ltd.	5.2%		$41,215,510	5,547,175			$7.43	13G	07 Apr 2025	14 Apr 2025, 17:10

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.09%	-0.22%	$8,821,016	2,513,110	-5,955,234	-70%	$3.51	Q4 2025
30 Sep 2025	0.37%	+0%	$27,606,801	8,468,344	+104,531	+1.2%	$3.26	Q3 2025
30 Jun 2025	0.31%	+0.12%	$20,491,342	8,363,813	+3,164,595	+61%	$2.45	Q2 2025
31 Mar 2025	0.62%	+0%	$34,678,784	5,199,218	+318		$6.67	Q1 2025
31 Dec 2024	1.2%	+0.24%	$65,350,173	5,198,900	+1,080,228	+26%	$12.57	Q4 2024
30 Sep 2024	1.5%	+0.07%	$76,071,872	4,118,672	+190,360	+4.8%	$18.47	Q3 2024
30 Jun 2024	1.6%	+0.02%	$84,576,557	3,928,312	+40,000	+1%	$21.53	Q2 2024
31 Mar 2024	2%	-0.08%	$104,751,125	3,888,312	-145,756	-3.6%	$26.94	Q1 2024
31 Dec 2023	2.5%	-0.99%	$120,901,018	4,034,068	-1,595,902	-28%	$29.97	Q4 2023
30 Sep 2023	2.7%	+0.6%	$115,358,085	5,629,970	+1,250,000	+29%	$20.49	Q3 2023
30 Jun 2023	1.9%	-0.01%	$87,030,004	4,379,970	-27,653	-0.63%	$19.87	Q2 2023
31 Mar 2023	1.9%	+0.45%	$75,502,582	4,407,623	+1,011,805	+30%	$17.13	Q1 2023
31 Dec 2022	1.6%	+0.41%	$66,456,158	3,395,818	+863,452	+34%	$19.57	Q4 2022
30 Sep 2022	0.91%	0%	$40,417,000	2,532,366	0		$15.96	Q3 2022
30 Jun 2022	0.87%	+0.14%	$34,845,000	2,532,366	+399,200	+19%	$13.76	Q2 2022
31 Mar 2022	0.61%	+0.07%	$33,832,000	2,133,166	+238,200	+13%	$15.86	Q1 2022
31 Dec 2021	0.5%	+0.06%	$41,367,000	1,894,966	+234,850	+14%	$21.83	Q4 2021
30 Sep 2021	0.55%	+0.49%	$49,621,000	1,660,116	+1,486,229	+855%	$29.89	Q3 2021
30 Jun 2021	0.07%	+0.07%	$7,701,000	173,887	+173,887	NEW	$44.29	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.